Physicians’ diagnoses of probable gastroesophageal reflux disease (GERD) in infants who cry and spit up excessively often lead them to overmedicate healthy babies, according to new research.
Physicians’ diagnoses of probable gastroesophageal reflux disease (GERD) in infants who cry and spit up excessively often lead them to overmedicate healthy babies, according to new research.
The study investigating the routine use of drugs to treat infants for suspected GERD found that parents are likely to seek medication for their child’s symptoms even if their health care provider tells them that drugs are not effective.
Researchers gave 175 parents in a general pediatric clinic several hypothetical scenarios in which a doctor gives a healthy infant who cries and often spits up a diagnosis of GERD with offer of medication or in which a doctor does not label the symptoms as a disease and advises parents that the infant will outgrow the symptoms. Half the parents were told that existing medications for GERD were probably ineffective while the other half were not provided any information about effectiveness. Parents answered survey questions based on a scale of 0 to 5.
Parents who received the GERD diagnosis in the scenarios were more interested in using medications than parents who did not receive the label, even when told that medication was likely ineffective. Parents not given a diagnosis of GERD and not told the medications were ineffective also expressed interest in using the drugs.
The number of US infants aged younger than 1 year who were diagnosed with GERD and treated with proton pump inhibitors jumped 700% from 1999 to 2004. Although these medications are effective when GERD is confirmed by endoscopy, clinical trials have shown that acid-reducing drugs work no better than placebo for treating excessive crying and regurgitation in otherwise healthy infants.
Researchers conclude that doctors may inadvertently be encouraging the use of questionable medical intervention by using labels such as GERD that increase parents’ perceived need for treatment. Not only is medicating otherwise healthy infants a needless expense, they say, but the practice may be exposing these children to long-term adverse effects that have not been fully studied.
Stress ulcer prophylaxis does not provide prevention of gastrointestinal bleeding in neonates
December 4th 2023In a poster abstract presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting & Exhibition held in Anaheim, California, stress ulcer prophylaxis (SUP) did not appear to provide benefit for prevention of gastrointestinal bleeding and did not increase SUP-associated adverse effects.
Hematocrit levels in newborns: EPP vs DCC study reveals surprising findings
November 15th 2023A recent study in JAMA Network Open investigates the impact of extrauterine placental perfusion versus delayed cord clamping on hematocrit levels in newborns, shedding light on potential alternatives for optimizing infant outcomes during birth.
Preterm infant HRQOL: Long-term impacts and determinants
October 21st 2023A recent study was highlighted at the 2023 American Academy of Pediatrics National Conference & Exhibition that shed light on the long-term impact of very preterm birth on the health-related quality of life (HRQOL) of infants and identified key determinants.
Associations between prenatal metal mixture exposure and negative infant outcomes
September 19th 2023Francheska M. Merced-Nieves, PhD, Assistant professor, Departments of Pediatrics and the Institute for Exposomic Research of Environmental Medicine & Public Health, Icahn School of Medicine at Mount Sinai, explains the associations prenatal exposure to a metal mixture and the potential negative effects for the infant.